Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Henning K, Nielsen"'
Autor:
Michael Moesmann, Madsen, Lone, Kærsvang, Anders Würgler, Hansen, Morten, Flink, Henning K, Nielsen, Klavs Würgler, Hansen
Publikováno v:
Danish medical journal. 65(9)
The Danish Adult Diabetes Database (DADD) annually reports a quality indicator for lipid-lowering treatment of type 2 diabetes mellitus (T2DM) patients. This retrospective cohort study aims to A) investigate the reasons for inadequate or lacking lipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b85944499d6ec7e7994b6161a54b59e4
https://pubmed.ncbi.nlm.nih.gov/30187860
https://pubmed.ncbi.nlm.nih.gov/30187860
Autor:
Henning K. Nielsen, Jens Bollerslev, Erik Fink Eriksen, Pernille Hermann, Peter Vestergaard, Lars Rejnmark, Kim Brixen, Moustapha Kassem, Bente L. Langdahl, Peder Charles
Publikováno v:
Rejnmark, L, Brixen, K, Kassem, M, Hermann, P, Vestergaard, P, Eriksen, E F, Bollerslev, J, Nielsen, H K, Charles, P & Langdahl, B 2018, ' Leif Mosekilde ', Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 33, no. 11 . https://doi.org/10.1002/jbmr.3588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334b30ff2eb06a9cb42d14287c26a285
https://pure.au.dk/portal/da/publications/leif-mosekilde(eb334920-22a8-4065-bdf8-2899b3464f00).html
https://pure.au.dk/portal/da/publications/leif-mosekilde(eb334920-22a8-4065-bdf8-2899b3464f00).html
Publikováno v:
Journal of Bone and Mineral Research. 6:435-441
Suppression of osteoblastic function plays an important pathogenic role for the development of glucocorticosteroid-induced osteoporosis. Serum osteocalcin (OC) is a sensitive marker of bone formation. The diurnal rhythm in serum OC can be changed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa615d98d50976688f774c4b236c359
https://doi.org/10.1002/jbmr.5650060503
https://doi.org/10.1002/jbmr.5650060503
Publikováno v:
Journal of Bone and Mineral Research. 5:609-618
The effects of recombinant human growth hormone (rhGH) on biochemical markers of bone turnover and bone mineral content (BMC) were investigated in 20 normal male volunteers (aged 22-31 years) randomized to treatment for 7 days with either rhGH (0.1 I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346609eec4bdab737dde8ee74be5e60b
https://doi.org/10.1002/jbmr.5650050610
https://doi.org/10.1002/jbmr.5650050610
Publikováno v:
Acta Medica Scandinavica. 224:479-483
Biochemical markers of bone resorption and bone formation were measured in 14 patients with autosomal dominant osteopetrosis, and compared with age- and sex-matched controls. There were eight patients with the radiological type I characterized by dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6e5c0a30cdec9b8ce0c1b0aecab01f
https://doi.org/10.1111/j.0954-6820.1988.tb19614.x
https://doi.org/10.1111/j.0954-6820.1988.tb19614.x
Publikováno v:
Calcified Tissue International. 51:276-281
To investigate the possible use of oral phosphate as an activator of bone remodeling in coherence treatment of osteoporosis, 82 postmenopausal females, aged 50-75 years, were randomized to treatment with oral phosphate (750, 1500, or 2550 mg/day) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c5133c7b309e1998e47a2bd9e41cd1
https://doi.org/10.1007/bf00334487
https://doi.org/10.1007/bf00334487
Publikováno v:
Acta Endocrinologica. 125:609-613
To investigate bone collagen metabolism during vitamin D treatment, 15 healthy males (aged 28-45 years, median 34) were treated orally with calcitriol, 2 μg daily for 7 days and followed for a total of 2 weeks. The serum concentration of calcitriol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a549f52cf8275c6376186312f2f8656
https://doi.org/10.1530/acta.0.1250609
https://doi.org/10.1530/acta.0.1250609
Publikováno v:
Calcified Tissue International. 49:373-377
We examined the role of sleep, growth hormone (GH), and parathyroid hormone [PTH(1-84)] as regulators of the diurnal rhythm of the osteoblastic bone marker, serum osteocalcin (OC). Nine normal subjects were followed with hourly blood sampling during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2d7374a3d46eaea18c76fbdb618ea2
https://doi.org/10.1007/bf02555845
https://doi.org/10.1007/bf02555845
Publikováno v:
Acta Endocrinologica. 124:391-398
Serum osteocalcin varies in a diurnal rhythm, with peak values during the night and minimum levels before noon, but the factors controlling this rhythm are unknown. In this study, we evaluated the temporal relations between the osteocalcin rhythm and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873f5b2cccec9593e6fc620ff4524efc
https://doi.org/10.1530/acta.0.1240391
https://doi.org/10.1530/acta.0.1240391
Publikováno v:
Calcified Tissue International. 48:82-87
Serum osteocalcin and bone alkaline phosphatase (BAP) were measured in samples drawn at 8 a.m. in 7 patients with GH deficiency treated with recombinant human growth hormone (rhGH) (2 IU/day subcutaneously at 8 p.m.), and 7 normal controls. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b38cb198c66e432a5cb9c05a14a5264
https://doi.org/10.1007/bf02555871
https://doi.org/10.1007/bf02555871